exploring the role of upfront autosct in multiple myeloma
Published 8 months ago β’ 50 plays β’ Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:59
the role of upfront double auto-sct in high-risk myeloma
-
7:10
the current state of the art in r/r multiple myeloma: a european perspective
-
1:53
canova trial: vendex versus pomdex in patients with r/r multiple myeloma
-
7:07
multiple myeloma coverage on vjhemonc!
-
1:47
trials exploring the safety and efficacy of modakafusp alfa in r/r multiple myeloma: iinnovate
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
5:19
a 17-year fight against multiple myeloma
-
11:16
garden by the bay singapore πΈπ¬ ar walking tour
-
1:53
the future of multiple myeloma treatment
-
3:06
multiple myeloma: adcs and bites
-
4:40
management of r/r myeloma and mrd assessment
-
4:27
antibody-based targeting of bcma in multiple myeloma
-
2:55
covid-19 & multiple myeloma: patient management
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl
-
2:32
updates on the use of melflufen in r/r multiple myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
1:33
circulating tumor cells in multiple myeloma
-
5:18
immunomodulation for improving long-term outcomes in myeloma
-
5:40
positioning immunotherapies in the changing paradigm of myeloma treatment
-
2:23
multiple myeloma: extramedullary disease
-
2:46
managing patients with high-risk myeloma